Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Ayr Wellness ( ($TSE:AYR.A) ).
AYR Wellness has announced an extension of its Limited Waiver Agreement with the majority of its senior noteholders, pushing the temporary waiver period to July 29, 2025. This extension allows AYR to continue its operations without the immediate threat of default-related actions, as it addresses delays in financial filings and payment defaults, while also exploring growth opportunities in key markets.
The most recent analyst rating on ($TSE:AYR.A) stock is a Buy with a C$3.50 price target. To see the full list of analyst forecasts on Ayr Wellness stock, see the TSE:AYR.A Stock Forecast page.
Spark’s Take on TSE:AYR.A Stock
According to Spark, TipRanks’ AI Analyst, TSE:AYR.A is a Underperform.
Ayr Wellness faces significant financial and operational challenges. Declining profitability, high leverage, negative cash flow, and adverse corporate events weigh heavily on the stock. Technical indicators also suggest bearish momentum. Investors should be cautious given the financial instability and strategic uncertainties.
To see Spark’s full report on TSE:AYR.A stock, click here.
More about Ayr Wellness
AYR Wellness is a vertically integrated U.S. multi-state cannabis business, operating over 90 licensed dispensaries and offering a range of cannabis consumer packaged goods (CPG) brands. The company is dedicated to providing high-quality cannabis products to its customers and communities.
YTD Price Performance: -79.05%
Average Trading Volume: 112,085
Technical Sentiment Signal: Sell
Current Market Cap: C$18.1M
Find detailed analytics on AYR.A stock on TipRanks’ Stock Analysis page.